Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
India · Delayed Price · Currency is INR 521.85
+1.00 (0.19%)
Nov 11, 2026, 1:54 PM IST
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 10.45 billion as of November 10, 2026. Its market cap has increased by 0.02% in one year.
Market Cap
10.45B
Enterprise Value
7.72B
Revenue
7.22B
Global Rank
n/a
Country Rank
n/a
PE Ratio
10.79
ChartMarket Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 10.45B, an increase of 7,422.78%. That is a compound annual growth rate of 21.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 10.45B | 7.97% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 30.11B |
| Sakar Healthcare | 21.69B |
| Windlas Biotech | 20.59B |
| Indoco Remedies | 19.85B |
| Beta Drugs | 18.31B |
| Anlon Healthcare | 14.35B |
| Jagsonpal Pharmaceuticals | 14.06B |
| Bafna Pharmaceuticals | 10.75B |